• Profile
Close

Optimal iodine supplementation during anti-thyroid drug therapy for Graves' disease is associated with lower recurrence rates than iodine restriction

Clinical Endocrinology Jan 06, 2018

Huang H, et al. - The researchers performed this study to elucidate whether optimal iodine supplementation during anti-thyroid drug therapy for Graves’ disease (GD) was correlated with lower recurrence rates than iodine restriction. For GD, optimal dietary iodine supplementation during anti-thyroid drug therapy was associated with lower recurrence rates than iodine restriction. Thus, in the management of GD, diet control with strict iodine restriction could be an adverse factor.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay